Biogen (BIIB) shares outstanding: 147.8M
Biogen had 147.8M shares outstanding on Oct 26, 2026, up 0.8% from 146.7M a year earlier.
From Biogen's filings with the SEC · BIIB stock page
Biogen shares outstanding by year
#913 of 3,715 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Oct 26, 2026 | 147.8M | +1% |
| Oct 29, 2025 | 146.7M | +1% |
| Oct 29, 2024 | 145.7M | +1% |
| Nov 7, 2023 | 144.9M | +1% |
| Oct 24, 2022 | 144.0M | – |
Shares outstanding of similar companies
Companies in the same industry as Biogen, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| Vir Biotechnology | 171.3M | Oct 28, 2026 |
| Novavax | 165.0M | Oct 31, 2026 |
| Adaptive Biotechnologies | 161.9M | Oct 30, 2026 |
| Denali Therapeutics | 160.3M | Oct 28, 2026 |
| Vaxcyte | 158.3M | Nov 2, 2026 |
| BIO-TECHNE | 157.1M | Oct 9, 2026 |
| Biogen | 147.8M | Oct 26, 2026 |
Questions and answers
What is Biogen's shares outstanding?
Biogen had 147.8M shares outstanding on Oct 26, 2026, up 0.8% from 146.7M a year earlier.
Numbers as reported in Biogen's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology